BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2019 10:13:56 AM | Browse: 845 | Download: 1687
 |
Received |
|
2019-03-25 01:27 |
|
Peer-Review Started |
|
2019-03-26 00:36 |
|
To Make the First Decision |
|
2019-04-18 03:53 |
|
Return for Revision |
|
2019-04-24 09:08 |
|
Revised |
|
2019-05-10 23:36 |
|
Second Decision |
|
2019-05-22 09:53 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-05-23 12:57 |
|
Articles in Press |
|
2019-05-23 12:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-05-28 01:26 |
|
Typeset the Manuscript |
|
2019-07-23 00:36 |
|
Publish the Manuscript Online |
|
2019-07-26 10:13 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Reproductive Biology |
| Manuscript Type |
Case Report |
| Article Title |
Multiline treatment of advanced squamous cell carcinoma of lung: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xin Yang, Ping Peng and Li Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li Zhang, MD, PhD, Associate Professor, Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1099 Jiefang Avenue, Qiaokou District, Wuhan 430000, Hubei Province, China. lizhang@tjh.tjmu.edu.cn |
| Key Words |
Squamous cell carcinoma; Chemotherapy; Nab-paclitaxel; Anaplastic lymphoma kinase-targeted therapy; Antiangiogenic therapy; |
| Core Tip |
Patients with advanced squamous cell carcinoma (SCC) have a poor prognosis and their treatment options are limited. Nab-paclitaxel has a superior antitumor effect and plays a significant role in the treatment of advanced non-small cell lung cancer, especially SCC; radiotherapy, anaplastic lymphoma kinase-targeted therapy and antiangiogenic therapy also make a great contribution to the patients’ survival. We should attach importance to multiline therapy and be flexible in our choice of the most suitable therapy method for those patients with SCC, including advanced cases. |
| Publish Date |
2019-07-26 10:13 |
| Citation |
Yang X, Peng P, Zhang L. Multiline treatment of advanced squamous cell carcinoma of lung: A case report and review of literature. World J Clin Cases 2019; 7(14): 1899-1907 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i14/1899.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i14.1899 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
